ArticleChest2023

Do Patients With Low-Risk Pulmonary Arterial Hypertension Really Benefit From Upfront Combination Therapy?: Insight From the AMBITION Trial.

Charles Fauvel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.